Skip to main content

Table 5 KRAS mutations in 159 lung cancers

From: Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland

 

cDNA change

Amino acid change

Frequency

Percentage

Codon 12/Exon 2

c.34G > T

p.G12C

72

45.3

Codon 12/Exon 2

c.35G > T

p.G12 V

26

16.4

Codon 12/Exon 2

c.35G > A

p.G12D

20

12.6

Codon 12/Exon 2

c.35G > C

p.G12A

15

9.4

Codon 12/Exon 2

c.34_35del

p.G12F

3

1.9

Codon 12/Exon 2

c.34G > C

p.G12R

2

1.3

Codon 12/Exon 2

c.34G > A

p.G12S

1

0.6

Codon 13/Exon 2

c.37G > T

p.G13C

10

6.3

Codon 13/Exon 2

c.37G > A

p.G13S

2

1.3

Codon 13/Exon 2

c.38G > A

p.G13D

2

1.3

Codon 13/Exon 2

c.37G > C

p.G13R

1

0.6

Codon 61/Exon 3

c.183A > C

p.Q61H

3

1.9

Codon 61/Exon 3

c.182A > T

p.Q61L

2

1.3

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us